Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 3/20 | 0.56 |
| ▸ | BACE1 | P56817 | 13/20 | 0.49 |
| ▸ | CTSD | P07339 | 4/20 | 0.49 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.43 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29630774 | 1.00 | ECE1 (0.56) | ECE1BACE1CTSDPDCD1LG2CD274 | |
| SCHEMBL30538341 | 0.94 | ECE1 (0.50) | ECE1BACE1CTSD | |
| SCHEMBL30063231 | 0.91 | ECE1 (0.47) | ECE1BACE1CTSDPDCD1LG2CD274 | |
| SCHEMBL30122872 | 0.90 | ECE1 (0.52) | ECE1BACE1CTSD | |
| SCHEMBL29798316 | 0.90 | BACE1 (0.52) | ECE1BACE1CTSD | |
| SCHEMBL29630557 | 0.89 | ECE1 (0.57) | ECE1BACE1CTSDPDCD1LG2CD274 | |
| SCHEMBL30122820 | 0.89 | ECE1 (0.57) | ECE1BACE1CTSDPDCD1LG2CD274 | |
| SCHEMBL29630762 | 0.89 | ECE1 (0.57) | ECE1BACE1CTSDPDCD1LG2CD274 | |
| SCHEMBL29630811 | 0.89 | ECE1 (0.57) | ECE1BACE1CTSDPDCD1LG2CD274 | |
| SCHEMBL29630837 | 0.89 | ECE1 (0.57) | ECE1BACE1CTSDPDCD1LG2CD274 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230355737-A1 | PARTICLE COMPRISING AN RSV-F PROTEIN FOR USE IN RSV VACCINATION | VIROMETIX AG (CH) | 2023-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230355737-A1 | PARTICLE COMPRISING AN RSV-F PROTEIN FOR USE IN RSV VACCINATION | CUTA, RRP12, VAC14 | ECE1 3792/4885BACE1 1329/4885CTSD 2243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.